Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion

被引:18
作者
Bahi, Amine
Boyer, Frederic
Kafri, Tal
Dreyer, Jean-Luc
机构
[1] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
[2] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
关键词
addiction; in vivo gene transfer; lentivirus; plasticity; small interfering RNA; urokinase-type plasminogen activator;
D O I
10.1111/j.1471-4159.2006.04013.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serine proteases in the nervous system have functional roles in neural plasticity. Among them, urokinase-type plasminogen activator (uPA) exerts a variety of functions during development, and is involved in learning and memory. Furthermore, psychostimulants strongly induce uPA expression in the mesolimbic dopaminergic pathway. In this study, doxycycline-regulatable lentiviruses expressing either uPA, a dominant-negative form of uPA, or non-regulatable lentiviruses expressing small interfering RNAs (siRNAs) targeted against uPA have been prepared and injected into the ventral tegmental area (VTA) of rat brains. Over-expression of uPA in the VTA induces doxycycline-dependent expression of its receptor, uPAR, but not its inhibitor, plasminogen activator inhibitor-1 (PAI-1). uPAR expression in the VTA is repressed upon silencing of uPA with lentiviruses expressing siRNAs. In addition, over-expression of uPA in the VTA promotes a 15-fold increase in locomotion activity upon cocaine delivery. Animals expressing the dominant-negative form of uPA did not display such hyperlocomotor activity. These cocaine-induced behavioural changes, associated with uPA expression, could be suppressed in the presence of doxycycline or uPA-specific siRNAs expressing lentiviruses. These data strongly support the major role of urokinase in cocaine-mediated plasticity changes.
引用
收藏
页码:1619 / 1631
页数:13
相关论文
共 67 条
[51]   The presynaptic calcium channel is part of a transmembrane complex linking a synaptic laminin (α4β2γ1) with non-erythroid spectrin [J].
Sunderland, WJ ;
Son, YJ ;
Miner, JH ;
Sanes, JR ;
Carlson, SS .
JOURNAL OF NEUROSCIENCE, 2000, 20 (03) :1009-1019
[52]   Critical role of integrin α5β1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling [J].
Tarui, T ;
Andronicos, N ;
Czekay, RP ;
Mazar, AP ;
Bdeir, K ;
Parry, GC ;
Kuo, A ;
Loskutoff, DJ ;
Cines, DB ;
Takada, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :29863-29872
[53]  
Todaro LB, 2003, ONCOL REP, V10, P725
[54]  
TOWLE MJ, 1993, CANCER RES, V53, P2553
[55]   Tissue plasminogen activator as a modulator of neuronal survival and function [J].
Tsirka, SE .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :222-225
[56]   EXCITOTOXIN-INDUCED NEURONAL DEGENERATION AND SEIZURE ARE MEDIATED BY TISSUE-PLASMINOGEN ACTIVATOR [J].
TSIRKA, SE ;
GUALANDRIS, A ;
AMARAL, DG ;
STRICKLAND, S .
NATURE, 1995, 377 (6547) :340-344
[57]  
Tsirka SE, 1997, J NEUROSCI, V17, P543
[58]   THE PLASMINOGEN-ACTIVATOR PLASMIN SYSTEM [J].
VASSALLI, JD ;
SAPPINO, AP ;
BELIN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (04) :1067-1072
[59]   Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor [J].
Wang, AY ;
Dang, JJ ;
Wang, H ;
Allgayer, N ;
Murrell, GAC ;
Boyd, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (11) :3248-3254
[60]   Posttranscriptional regulation of urokinase plasminogen activator receptor messenger RNA levels by leukocyte integrin engagement [J].
Wang, GJ ;
Collinge, M ;
Blasi, F ;
Pardi, R ;
Bender, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6296-6301